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Abstract
Background: Evidence from the USA suggests that the home-based Family Nurse Partnership program (FNP),
extending from early pregnancy until infants are 24 months, can reduce the risk of child abuse and neglect
throughout childhood. FNP is now widely available in the UK. A new variant, Group Family Nurse Partnership
(gFNP) offers similar content but in a group context and for a shorter time, until infants are 12 months old. Each
group comprises 8 to 12 women with similar expected delivery dates and their partners. Its implementation has
been established but there is no evidence of its effectiveness.
Methods/Design: The study comprises a multi-site randomized controlled trial designed to identify the benefits of
gFNP compared to standard care. Participants (not eligible for FNP) must be either aged < 20 years at their last
menstrual period (LMP) with one or more previous live births, or aged 20 to 24 at LMP with low educational
qualifications and no previous live births. ‘Low educational qualifications’ is defined as not having both Maths and
English Language GCSE at grade C or higher or, if they have both, no more than four in total at grade C or higher.
Exclusions are: under 20 years and previously received home-based FNP and, in either age group, severe psychotic
mental illness or not able to communicate in English. Consenting women are randomly allocated (minimized by
site and maternal age group) when between 10 and 16 weeks pregnant to either to the 44 session gFNP program
or to standard care after the collection of baseline information. Researchers are blind to group assignment.
The primary outcomes at 12 months are child abuse potential based on the revised Adult-Adolescent Parenting
Inventory and parent/infant interaction coded using the CARE Index based on a video-taped interaction. Secondary
outcomes are maternal depression, parenting stress, health related quality of life, social support, and use of services.
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Discussion: This is the first study of the effectiveness of gFNP in the UK. Results should inform decision-making
about its delivery alongside universal services, potentially enabling a wider range of families to benefit from the
FNP curriculum and approach to supporting parenting.
Trial registration: ISRCTN78814904.
Keywords: Early intervention, Child abuse, Nurse, Young parents
Background
Recent estimates show that suboptimal parenting of in-
fants is a major public health issue. As of 31 March 2012,
infants (children aged up to one year) accounted for 13%
of those who were subject to a child protection plan in
England [1]. The most common initial category of abuse
for infants was neglect (49%) followed by emotional abuse
(22%) and physical abuse (16%). Infants also face four
times the average risk of homicide, perpetrators being
parents in most cases [2]. Non-accidental head injuries are
high resulting in up to 30% mortality and significant
neurological impairment for survivors [3]. Furthermore,
abuse of very young children may be up to 25% higher
than indicated by official estimates [4]. In addition to
preventing childhood injury and abuse, sensitive care-
giving during the first year is important for promoting
optimal child outcomes because brain development then
is rapid and vulnerable to negative influences [5]. Trauma
and adverse parent–child interactions in infancy elevate
cortisol, a strong indicator of stress, and can lead to at-
tachment difficulties, hyperactivity, anxiety and impulsive
behavior [6,7].
Overall, evidence concerning the effectiveness of home
visiting programs in reducing child maltreatment is in-
conclusive [8] but the Nurse Family Partnership (NFP)
was one of nine home visiting programs identified by
the United States Department of Health and Human
Services (HHS) as part of their Home Visiting Evidence
of Effectiveness (HomVEE) review. The NFP was found
to be effective in both decreasing child maltreatment
and improving parenting practices [9]. Long-term
follow-up of the FNP suggests a 48% reduction in cases
of child abuse and neglect by age 15 [10].
The NFP curriculum has strong theoretical underpin-
nings, both in terms of risk and protective factors, and
the mechanisms through which change may be pro-
duced [11], drawing on ecological [12], self-efficacy [13]
and attachment [14] theories. Ecological theory empha-
sizes the importance of interactions between the charac-
teristics of individuals and their contexts; self-efficacy
theory focuses on an individual’s beliefs that they can
successfully carry out behavior required for good out-
comes; and attachment theory highlights the importance
of the early interactions with the primary caregiver in
terms of the child’s later capacity for affect regulation.
The cornerstone of the NFP model is the therapeutic
nurse-client relationship. Beneficial outcomes found in
the US trials include improved prenatal health, fewer
childhood injuries, fewer subsequent pregnancies, in-
creased intervals between births, increased maternal
employment and improved school readiness [10,15-18];
it has also been shown to have the potential to be cost
effective [19]. Results from the US trials of NFP found
that it was particularly beneficial for women with ‘low
psychological resources’, namely a combination of lower
intelligence, mental health problems and low self-
efficacy [20]. NFP is now being offered in England,
where it is known as the Family Nurse Partnership
(FNP), and has been successfully implemented across a
range of settings [21-23]. It is currently available in more
than 50 locations with further expansion planned [24].
There are, however, mothers-to-be who might benefit
from the FNP program but who are not eligible because
they are teenage and already had a previous live birth or
are over the age of 19 [25]. Group FNP (gFNP) was
designed as a program that could be offered to woman
not eligible for FNP.
Group Family Nurse Partnership
Group FNP was developed in 2009, jointly by the UK
FNP National Unit and the US NFP National Office led
by Professor David Olds, as a way to use the expertise of
the FNP nurses and the learning from the FNP to reach
women whose children were at risk of poor outcomes
but offered in a different context and to those not
eligible for FNP. The newly developed program has the
same theoretical basis as the home-based program but is
delivered in a local children’s center (or similar com-
munity location). The aims of the gFNP program are to
improve birth outcomes, develop a warm and authorita-
tive parenting style underpinned by good attachment
and knowledge of babies’ developmental needs, promote
effective local support networks through contact with
other parents, increase take-up of local services, and
greater parental self-efficacy to make positive life choices
and plan for their future through, for example, thinking
about gaining educational qualifications or training for
employment. While FNP continues until infants are
Barnes et al. Trials 2013, 14:285 Page 2 of 12
http://www.trialsjournal.com/content/14/1/285
24 months old gFNP runs until infants are 12 months of
age [26].
The sites delivering gFNP are established FNP sites
and gFNP will be delivered in addition to the one to one
FNP program in those sites, to clients who would are
ineligible for FNP. The program is delivered to each
group by two family nurses trained according to US NFP
guidelines and who are experienced in delivering home-
based FNP [26], one of whom is a practising midwife.
Each group comprises between 8 and 12 women, whose
partners are encouraged to attend. Women using group
based antenatal care such as the Centering Pregnancy
Model [27], reported a preference for this approach over
traditional care [28-30]. Centering Pregnancy has been
associated with improved prenatal outcomes such as
reductions in preterm births among high-risk women
[31,32]. Following this model of delivery, gFNP provides
routine midwifery care in pregnancy and infant health
checks according to NICE guidelines [33] during the
gFNP session with encouragement for mothers to con-
duct the necessary pregnancy checks themselves with
guidance from the family nurses and midwives. Any out-
of-hours antenatal care is managed according to local
arrangements (this may involve a community midwifery
team or hospital) and intrapartum care is managed by
the hospital/birth center midwifery team. The group
context should help mothers to develop social networks
with other local mothers [34], and to benefit from peer-
group learning. Also, meeting in Children’s Centers
helps families to become familiar with the other services
and to develop regular contact with other professionals
when additional support is called for [35].
An implementation evaluation in England found that
both the mode of delivery and materials were acceptable
to clients and nurses [34-36]. In addition to developing
relationships with the family nurses, clients have deve-
loped close relationships with group members and made
regular use of other services in the Children’s Centers.
The delivered content of gFNP is consistent with NFP
US National Office recommendations [36] and the
prediction is that gFNP is likely to be associated with
the same kinds of benefits as the individually delivered
program. However, in order to provide optimal infor-
mation for service providers and commissioners, and to
provide the most effective support for potentially vulne-
rable families, it is important that programs be subject
to rigorous randomized trials to provide evidence about
efficacy and cost-effectiveness.
Aims of the study
The main objective of this study is to evaluate whether
provision of the Group Family Nurse Partnership (gFNP)
program, compared to routine antenatal and postnatal
services, can enhance parenting and reduce risk factors
for maltreatment in expectant mothers aged < 20 with
one or more previous live births or expectant mothers
aged 20 to 24 with low/no educational qualifications and
no previous live births.
Secondary objectives are to determine whether pro-
vision of gFNP will enhance maternal physical and men-
tal health in pregnancy and the experience of pregnancy
and delivery for mothers and fathers; to determine
whether gFNP will enhance infant birth status and
health status in infancy, breast feeding in the first two
months, and immunization take-up during the first year;
to identify whether gFNP is cost effective in comparison
with routinely available services; and to identify how the
program is experienced by women who have a history of
being in the care of social services (known as having
been ‘looked after’) in comparison with receiving rou-
tinely available services.
Methods/Design
Study design
The study comprises a multi-site randomized controlled
trial in which eligible women are allocated (minimized
by site and maternal age group) to one of two arms:
i) gFNP delivered via 44 sessions delivered over 76 weeks
(N = 100); ii) standard care (N = 100). In addition to the
quantitative measures used to compare the two groups
qualitative methods will be used to provide a better
understanding of the results obtained in the trial.
Study setting
Sites were included if they responded to an invitation to
take part from the FNP National Unit, could demon-
strate sufficient women of the relevant age and parity
who had given birth in the previous year, and could con-
firm good links with community midwifery, who also
had to sign the expression of interest. Only FNP teams
who had delivered the home-based FNP program in its
entirety (from birth to child age 24 months) to a cohort
of women and with a practising midwife in the team
were eligible.
The gFNP program is delivered by two family nurses,
one of whom is a practising midwife, in community set-
tings such as Sure Start Children’s Centers, located so
that the amount of travelling necessary by group parti-
cipants is kept to a minimum. Proximity to the location
should enhance the rate of attendance and also foster
the formulation of social networks. However, so that
women from a potentially wider range of home ad-
dresses can be recruited to ensure the sample size, funds
are available to reimburse intervention participants for
travel by public transport to the intervention sessions.
Child care is available for any other children. The gFNP
program runs from approximately the 16th week of
pregnancy to when the babies are 12 months old,
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meeting weekly or fortnightly during the daytime
depending on the stage of the program (14 pregnancy
sessions and 30 infancy sessions).
The control group mothers and infants would not be
eligible for home-based FNP but will receive all the
Universal Core Offer recommended in the Healthy Child
Program through midwifery and health visiting services
[37]. This is a substantial and universal service for ex-
pectant mothers and their infants with a strong evidence
base [38] supported by systematic review evidence and
NICE guidance. It offers screening tests, immunizations,
developmental reviews, information and guidance to
support parenting. The latest version has a strong em-
phasis on pregnancy and the first year of life. Commu-
nity midwives and health visitors may provide or refer to
a range of other community-based or specialist services
designed to support young mothers.
Data collection for the study will be conducted by
researchers blind to allocation in three visits to partici-
pant’s homes (baseline in pregnancy, when infants are
two months and twelve months of age), and one tele-
phone contact (when infants are six months old).
Ethical and research governance approval
The study has been granted ethical approval by the
NRES Committee South West-Frenchay (REC reference
13/SW/0086).
Study timeline
The trial commenced in February 2013 and will be com-
pleted in January 2016. Recruitment commenced in July
2013 and takes place in seven sites in England (Barnsley,
Dewsbury, Lewisham, Nottingham, Sandwell, South
Tyne and Wear and Waltham Forest) through until
January 2014. Figure 1 provides details of the timeline
for each participant, which will extend from the time
that they book in with their midwife (on average at 8 to
12 weeks gestation) through to the end of the study,
when their infants are at least 12 months old. The
specific time will vary depending on their gestation at
booking but will range from 82 to 86 weeks. The
intervention arm will receive the gFNP program for
76 weeks on average (from 16 weeks gestation to infant
12 months).
Randomization
The process will be overseen by the London School of
Hygiene and Tropical Medicine Clinical Trials Unit
(LSHTM CTU). Identifying information and baseline
details of eligible consenting mothers-to-be will be pro-
vided by the researchers to the central randomization ser-
vice at Health Service Research Unit (HSRU), Aberdeen.
Minimization criteria will be used to ensure a balance
of key prognostic factors using the following two
criteria: site and age group (< 20, 20 to 24 years). Alloca-
tions to one of two arms will be securely computer gener-
ated and delivered by Email to LSHTM. The LSHTM
CTU will convey to each gFNP team the names and con-
tact details of women allocated to the intervention arm.
The researchers will be blind to allocation.
Study participants
Women eligible for the trial are expectant mothers prior
to 16 weeks gestation with expected delivery dates
(EDD) within six to eight weeks of each other for each
group in each site, with the range of EDDs specified in
relation to the expected date of the first meeting for that
site so that the majority would have a gestation of 16 to
20 weeks when the program commences. Specific cri-
teria beyond similar EDDs and gestation were developed
based on a formative evaluation [34-36] and on the
requirement of the UK FNP National Unit that gFNP
should be offered to women not eligible for FNP but be
likely to benefit from the content of program, based on
research in the USA [11,15]. Thus participants must be
either aged < 20 at their last menstrual period (LMP)
with one or more previous live births, or aged 20 to 24
at LMP with low educational qualifications and no pre-
vious live births. ‘Low educational qualifications’ is de-
fined as not having both Maths and English Language
GCSE at grade C or higher or, if they have both of these
GCSEs, no more than four GCSEs in total at grade C or
higher. Exclusions are: expectant mothers under the age
of 20 who have previously received home-based FNP,
those in either age group with psychotic mental illness
(defined as bi-polar disorder or schizophrenia), or those
who are not able to communicate in English since it is
not possible to deliver the program in a group context
unless all the participants can all understand and speak
English.
Sample size
The sample size was calculated for the two primary out-
comes, the revised Adult Adolescent Parenting Inven-
tory (AAPI-2) [39] and the observational CARE Index
[40-42]. The standard deviation (SD) of the AAPI-2 is
10, with differences of 6.7 identified in the normative
sample between abusive and non-abusive adult females
[39]. The standard deviation for the CARE Index is
expected to be around 2.3 [41].
For this individually randomized trial, we propose to
recruit sufficient mothers and babies (families) to allow
the trial to detect a difference between groups of 0.5
standard deviations, with 90% power at a significance
level of 0.05 (2-tailed); this is considered to represent a
moderate size of effect [43]. Basing calculation on the
AAPI-2, very conservatively assuming a correlation of
0.4 between pre and post intervention scores we would
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need at least 71 families in each arm of the trial to detect
this difference. Allowing for an expected 30% drop out
rate (based on the first two applications of the program
in England) we would need to recruit a minimum of 84
families per arm of the trial. We therefore propose, con-
servatively, to recruit a minimum of 100 families per
arm (N = 200). In the intervention arm this will consist
of 10 groups of (generally) 10 families (N = 100), with
Exclude no agreement to
share details
In each area, community midwifery identify potential participants by age and
parity. Give leaflet with brief study details. Gain agreement for contact details
to be shared.
Exclude if 20 – 24 and
both Maths and English
GCSE or 5+ GCSEs
Local Researcher contacts to make home visit, checks eligibility (age, parity
and educational qualifications if relevant)
and give more details of trial, asks about interest
Exclude not interested
Researcher telephones at least 24 hours later to get a verbal consent.
Arrange home visit for written informed consent and baseline Exclude no oral consent
or no written informed
consent
After completing baseline telephone HSRU, Aberdeen for allocation.
Allocated to intervention
12-16 weeks gestation
contact details given to FNP
team
N=100
Allocated to control group
12-16 weeks gestation
Usual services
N = 100
Researcher home visit
infant 2 months
Researcher home visit
Infant 2 months
Telephone Interview
Infant 6 months
Telephone Interview
Infant 6 months
Researcher home visit
infant 12 months
Researcher home visit
infant 12 months
Qualitative Interviews with
purposive sub-sample
N = 10
Qualitative interviews with
sub-sample who have
experience of being LAC
N = 10
Qualitative interivews with
sub-sample who have
experience of being LAC
N = 10
LSHTM CTU informs participant of allocation.
Figure 1 Flow chart of participants.
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2 groups provided per site. However, given that the
minimum number required for a viable group is 8, 7
sites are involved in the trial so that it will be possible to
recruit a minimum of 208 (if one site proves able to
deliver only one group of 8) and potentially at least 224
participants (2 groups of 8 per site plus the same
number of controls). It was necessary to have two more
sites than the five originally proposed to cope with the
possibility that in one or more areas area the minimum
number of women would not be recruited to form a
viable group. The proposed sample size would similarly
allow us to detect a change of approximately 0.5 stan-
dard deviations in the CARE index [40-42]. We would
therefore expect to be able to detect a difference at
follow-up between arms of the trial of approximately 1.2
with 90% power and a 5% level of significance.
Recruitment
Recruitment will be time-dependent in that a minimum
number of trial participants with expected delivery dates
(EDDs) that are within 8 weeks of each other must be
recruited within 6 weeks in each site for each delivery of
gFNP, namely at least 16 and ideally 20 (8 to 10 inter-
vention and 8 to 10 control) with a maximum number
per group of 12. In the recruitment process, community
midwives will identify women using the initial criteria of
age, parity and gestation. Guidelines will also be pro-
vided about the specific EDDs that are required for each
gFNP delivery in each site.
Midwives will give all potentially eligible women a
brochure describing the study, asking for agreement to
give their names and contact details to the local re-
searcher as part of a staged consent process, using an
‘agreement to contact’ form. Those agreeing will be
contacted by the local researcher. The first contact will
be by telephone to establish eligibility. Women who are
not eligible will be thanked for their time. Those who
are eligible will be given further information about the
trial, and time to think about participation. After at least
24 hours, the researcher will contact the women by tele-
phone and if telephone agreement is given the re-
searcher will make a home visit, obtain written consent
and collect baseline data. Participants will be reminded
about the services available in their area and that they
should keep their next midwifery appointment and
remind them about the next research contact. After
leaving, the local researcher will telephone the central
randomization service provided by HSRU Aberdeen to
randomize the participant, giving identifying details and
sufficient prognostic detail to allow minimization. Re-
searchers will be given a study number for the par-
ticipant but will remain blind to allocation, which will
be conveyed by HSRU Aberdeen to LSHTM CTU by
secure Email.
LSHTM CTU will inform all participants by first class
post of their allocation to the intervention or control
arm of the study. For women in the intervention arm,
the LSHTM team will inform the relevant FNP team by
fax, receipt confirmed by fax, of the women in the inter-
vention arm so that the gFNP intervention can be ini-
tiated. This process will continue until at least 16 and no
more than 24 women have been recruited in each site
for the first delivery of gFNP. If a second group is to be
offered in the same location, a second round of recruit-
ment will take place 12 weeks later, repeating the same
process.
As a strategy to limit attrition, participants will be
given ‘High Street’ vouchers for £20 at each home-visit
data collection point (baseline, two months postpartum
and twelve months postpartum) and a £10 voucher will
be posted after the six month telephone contact as ac-
knowledgement of their contribution, and to encourage
continuation with the study. In addition, details of
changes of address will be solicited by providing pre-
paid addressed envelopes and response cards at baseline
by sending birth congratulation cards and one year
birthday cards.
Data collection instruments
Primary outcome measures
Two primary outcome measures of parenting are being
used because of the difficulties associated with the detec-
tion of low frequency events such as child abuse. One is
a self-report measure of parenting opinions and the
others an objective measure of parent-infant interaction.
Both are known to be able to identify mothers at risk for
abusive parenting.
The revised AAPI-2 [39] is a 40 item self-report meas-
ure able to discriminate between abusive and non-abusive
parents. It includes five subscales: ‘inappropriate’ expecta-
tions of children, inability to demonstrate empathy to
children’s needs, strong belief in the use of corporal pun-
ishment, reversing parent–child family roles and op-
pressing children’s power and independence. Responses
are on a five-point Likert-type scale ranging from‘strongly
agree’ to ‘strongly disagree’. Internal reliability of the
subscales ranges from .83 to .93, Cronbach alphas range
from .80 to .92. The scales were constructed based on
factor analysis to demonstrate construct validity and the
inventory has discriminant validity comparing abusive and
non-abusive parents (sample 1,985).
The observational CARE Index [40,41] is based on a
video recording of three minutes mother-child play, and
measures three aspects of maternal behavior (sensitivity;
covert and overt hostility; unresponsiveness) and four
aspects of infant behavior (cooperativeness; compulsive
compliance; difficultness; and passivity). These are highly
correlated with attachment and differentiate between
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abusing, neglecting, abusing and neglecting, marginally
maltreating, and adequate dyads [42]. Scores range from
0 to 14, higher scores indicating better sensitivity and/
or co-operation. Scoring will be conducted blind to
allocation.
In addition the incidence of child abuse during the
child’s first year will be assessed by the number of case
conferences; the number of children with Child Protec-
tion Plan in place; and the number of children removed
from the home (all based on maternal reports at
12 months). The child’s attendance at hospital A&E
departments for non-accidental injuries or ingestions of
toxic substances will be confirmed using hospital epi-
sode statistics (HES) data.
Secondary outcome measures
Secondary outcomes will assess socio-emotional aspects
of parenting and family life and service use. Maternal
depression will be assessed (baseline, 2, 6 and 12 months
postpartum) using the Edinburgh Postnatal Depression
Scale [44], a well-validated 12 item measure of postnatal
depression with high reliability (0.88) and internal
consistency (0.87), 86% sensitivity and 78% specificity.
This questionnaire will be scored within 24 hours of its
administration so that any woman with a total score
above the recommended cut-off indicating a risk of
depression, or who responds affirmatively to the ques-
tion asking about self-harm, can be identified and a
health care professional contacted to give appropriate
support.
Maternal stress will be assessed (2 and 12 months
postpartum) using the Abidin Parenting Stress Index,
Short Form [45], a well-validated 36 item measure of
perceived stress in the parenting role with sound
test-retest reliability (r = .84) and internal consistency
(a = .91). High scores on the PSI have been associated
with abusive parenting [46,47] with some evidence that
parenting stress is higher in women with five or more
risk factors for child abuse [48]. In addition, parenting
sense of competence will be assessed with the Parenting
Sense of Competence (PSOC) scale [49] at two and
twelve months. This 17 item measure has three factors;
satisfaction, efficacy and interest established by factor
analysis in a normative non-clinical sample, each with
acceptable internal consistency (from 0.62 to 0.72) [50].
Maternal health-related quality of life (HRQoL) will be
assessed using the EuroQol EQ-5D-5 L measure [51] at
baseline, two, six and twelve months postpartum. This
contains a visual analogue scale asking patients to rate
their current HRQoL on a scale from 0 to 100, and a five
dimension health status classification system, which can
then be converted to a multi-attribute utility score by
applying a UK tariff [52]. Brief questions designed for
the study and based on those developed for use when
delivering FNP will ask about maternal smoking, alcohol
and drug use and relationship violence.
The extent of social support available to the mothers
will be assessed (baseline and 12 months) using the
Medical Outcomes Study (MOS) Social Support Survey
[53]. The 20 item scale measures four dimensions of sup-
port, established using confirmatory factor analysis: emo-
tional support, tangible support, positive interaction, and
affection, each with internal consistency of 0.91 or higher,
and also provided a total support score (Cronbach alpha
0.97); stability over time is also high for each scale (ran-
ging from 0.72 to 0.78) [53]. Use of local resources and
services will be assessed using questionnaires designed
specifically for this study. Brief questions designed for the
study will ask about infant feeding and the take-up of
recommended immunizations in the infant’s first year.
Process measures
Data forms completed after each group session by the
FNs delivering gFNP will provide information on inter-
vention participants’ attendance at each session, the
presence of partners and the extent of their understan-
ding and involvement in the content. The ID number
used by the FNs for program delivery data will be linked
with the trial number.
Qualitative semi-structured interviews will be con-
ducted with selected professionals in each locality to as-
certain the extent to which the referral pathways could
be strengthened, the likelihood that the service could be
successfully embedded in the area and its likely sustai-
nability. These interviews will take place after all re-
cruitment has been completed in each local area with
professionals likely, in the future, to be involved in
making referrals to the program (in total, at least five
community midwives and at least five other relevant
health professionals such as general practitioners). At
the completion of program delivery in each area, inter-
views will also be conducted with at least five commis-
sioners of children’s services and with two professionals
who are providers of care for ‘looked-after’ young
people.
So that the research does not influence the experience
of participants in the research, a number of interviews
will be conducted after completion of program delivery
in each group. At least one family nurse will be inter-
viewed per center and each FNP supervisor will be
interviewed about their thoughts on delivering the pro-
gram and its likely sustainability. They will also be asked
about the particular relevance of the gFNP program for
women or their partners who have a ‘looked-after’
history or who are currently under the care of social
services.
Participants’ views about the acceptability of the pro-
gram will be assessed using semi-structured face-to-face
Barnes et al. Trials 2013, 14:285 Page 7 of 12
http://www.trialsjournal.com/content/14/1/285
interviews with a purposive sample (informed by
program delivery data) of 20 women who were allocated
to receive gFNP support and 5 of their partners.
In-depth semi-structured interviews will be conducted
with up to 10 women allocated to receive gFNP (exclu-
ding those specified in the previous paragraph) who are
or who have a history of being looked after and, if avai-
lable, their partners, and a similar number of women
allocated to standard care to explore their perceptions of
the program, or any impacts, and other support needs.
Data management
Quantitative data (summarized in Table 1) will be col-
lected from both the intervention and control arms of
the study by study researchers in the participants’
homes and by telephone. The data will comprise a range
of self-report questionnaires. Response cards will be
used for questions that have a range of possible
responses. Home visits will be made at baseline, when
participants’ infants are two and twelve months old with
a telephone contact when infants are six months old. At
12 months postpartum, data collection will also include
independent video-recorded observations of the mother
and infant. Researchers will administer questionnaires
orally where required with the anticipation that some
participants may have low levels of literacy. Researchers
will be trained together to ensure that similar methods
are used in all locations and the trial manager will
accompany them on a percentage of home visits
throughout the study to maintain quality.
Data will be double entered to ensure quality and a
percentage of completed forms reviewed for quality. All
LSHTM data will be managed and stored in compliance
with ICH GCP 1996 following trial specific standard
operating procedures (SOP) as given in the trial master
file, and in accordance with LSHTM Information Ma-
nagement and Security Policy and LSHTM Data Pro-
tection Policy. Anonymized data will be stored securely
at the LSHTM and separately from any information
identifying participants. Paper forms will be stored in
numerical order in a secure and accessible place and
will be maintained in storage for a period of three years
after completion of the study. Electronic data will be
stored as csv files and Stata data files (.dta) in LSHTM
data centers which provide appropriate levels of envi-
ronmental and physical security on servers that are
managed in accordance with LSHTM Systems Manage-
ment Policy. Confidential information will be registered
with the LSHTM Archivist and Records Manager and
data will be stored on a secure server which maintains
an audit trail demonstrating system access. At the end
of the study, routinely collected HES data for trial
participants will be accessed for information on all hos-
pital health service activity during the period between
randomization and 12 month postpartum. HES data
cover hospital in-patient, outpatients, and accident and
emergency attendances.
Table 1 Details and timing of data collection
Measure Baseline, gestation 10 to
14 weeks
Infant 2 months,
home visit
Infant 6 months, telephone
interview
Infant 12 months,
home visit
Adult-Adolescent Parenting
Inventory (AAPI-2)
X X
CARE index X
Demographics X X (update) X (update) X (update)
Edinburgh Postnatal Depression
Scale (EPDS)
X X X X
Infant feeding X (plans) X X
Infant immunizations X X
Maternal drug use X X (update) X (update)
Maternal quality of life (EQ-5D 5L) X X X X
Maternal smoking and alcohol use X X (update) X (update)
Parenting stress index short form
(PSI)
X X
Perceived parenting competence
(PSOC)
X X
Relationship violence X X
Social networks (MOS) X X
Service use X X X
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Data analysis
Outcomes
Statistical analysis will be carried out at the individual
level. Every effort will be made to obtain outcome mea-
sures for participants, even if some drop out during the
course of the group sessions or move out of the local
area so have to stop attending gFNP.
Analyses will be carried out using two different types
of dataset:
i) The intention-to-treat datasets: data will be analyzed
based on participants according to the random
allocation irrespective of whether the intervention
was or was not entirely or partly taken up.
ii) The per-protocol datasets: as it is possible that
participants may not receive the intervention, the
intention-to-treat analysis might underestimate the
potential efficacy of intervention. A per-protocol
analysis will therefore be carried out in addition to
the intention-to-treat analysis. The per-protocol
datasets will include data pertaining to all outcomes,
restricted to those participants who complied fully
or partly with their assigned intervention.
The primary analysis will use the intention-to-treat
datasets. Demographic and other characteristics at trial
entry will be tabulated using the intention-to-treat
datasets. No significance tests will be performed to test
for differences at baseline. Descriptive statistics for con-
tinuous variables will include the mean, standard de-
viation, median, range and the number of observations.
Categorical variables will be presented as numbers and
percentages.
The data will be analyzed by multiple regression mode-
ling, with appropriate generalized linear models (GLMs)
used to examine the effect of the intervention, fitting base-
line measures of outcomes as covariates, where available.
A small number of secondary analyses based on explicit
hypotheses, for example, subgroup (including ‘looked
after’ history)/explanatory analyses (considering com-
pliance with the interventions) will be specified in advance
(in a statistical analysis plan). The secondary analyses will
include an analysis in which the small groups in which the
intervention is delivered will be fitted as a random effect
to allow for any potential clustering by group. Sensitivity
analyses will be conducted for all primary outcomes.
Inverse probability weighting would be considered if mis-
sing data were larger than expected and/or there was dif-
ferential attrition between the trial arms. Additionally,
reasons for the differential attrition will be fully explored.
Economic evaluation
A prospective economic evaluation, conducted from an
NHS and personal social services perspective, will be
integrated into the trial. The economic assessment
method will, as far as possible, adhere to the recommen-
dations of the NICE Reference Case [54]. Primary re-
search methods will be followed to estimate the costs of
the delivering gFNP, including development and training
of accredited providers, the cost of delivering the group
sessions, participant monitoring activities, and any
follow-up/management. Broader resource utilization will
be captured through two principal sources: (i) routine
health service data collection systems described above;
and (ii) patient questionnaires administered at baseline,
two months postpartum, and twelve months postpartum
with a telephone contact at six months to minimize loss
of information due to recall difficulties. Unit costs for
health and social care resources will largely be derived
from local and national sources and estimated in line
with best practice. Primary research using established ac-
counting methods may also be required to estimate unit
costs. Costs will be standardized to current prices where
possible.
Maternal health-related quality of life, measured at
baseline, two months postpartum, six months postpar-
tum and twelve months postpartum using the EuroQol
EQ-5D-5L [51] will be converted into health utilities
using established utility algorithms [52] for the purposes
of quality-adjusted life year (QALY) estimation. The
results of the economic evaluation will primarily be
expressed in terms of incremental cost per QALY gained.
Non-parametric bootstrap estimation will be used to
derive 95% confidence intervals for mean cost dif-
ferences between the trial groups and to calculate 95%
confidence intervals for incremental cost effectiveness
ratios [55]. A series of sensitivity analyses will explore
the implications of uncertainty on the incremental cost-
effectiveness ratios and will consider the broader issue of
the generalisability of the results. One such analysis will
adopt a societal perspective incorporating direct costs to
trial participants and their partners, informal care
provided by family and friends, and productivity losses.
In the baseline analysis, and for each sensitivity ana-
lysis, cost-effectiveness acceptability curves will be
constructed using the net benefits approach [56].
More extensive economic modeling using decision-
analytic methods will extend the time horizon of the
economic evaluation, drawing on best available infor-
mation from the literature together with stakeholder
consultations to supplement the trial data. Parameter
uncertainty in the decision-analytic model will be ex-
plored using probabilistic sensitivity analysis. Longer
term costs and consequences will be discounted to
present values using discount rates recommended for
health technology appraisal in the United Kingdom [54].
Given the plethora of outcome measures across several
domains for the mother, child and broader family, a
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separate discrete choice experiment (DCE) will be
conducted. The possibility of combining the outputs of
the DCE with cost estimates and changes in relevant
outcomes within a cost-benefit analysis framework will
be explored.
Process
Characteristics of study participants and those who de-
cline to participate or are ineligible will be identified
(demographic and risk profiles) and contrasted with
those of the wider population in the study areas. The
representativeness of recruited families will be assessed
by analyzing anonymized data for each expectant woman
approached: age; parity; any risk factors collected during
routine booking-in (for example, history of mental
health problems); in relation to their acceptance or
rejection of the agreement for researcher contact.
The uptake rate of women who agree to the interven-
tion will involve an assessment of the ratio of women
randomized to receive the intervention who then attend
at least one session relative to those who either refuse
after meeting with the family nurse, or who agree but
never attend any sessions. The study attrition rate will
be estimated in terms of the proportion of women who
drop out relative to those who continue in either arm of
the trial and also those who may or may not take part in
research visits but cease to receive the intervention,
based on information provided by the nurses delivering
the program. The extent to which the program is being
delivered with integrity will be assessed though analysis
of data from the program’s standardized data forms
documenting attendance, the content domains covered
in each session and participants’ responses to the con-
tent, comparing the information with recommendations
for delivery from the US NFP National Office and from
the UK FNP National Unit.
All qualitative interviews will be transcribed and ana-
lyzed thematically [57]. Interviews with women and their
partners with a looked-after history will be analyzed
using a computer-aided qualitative data analysis package
informed by interpretive phenomenology which seeks to
represent the experiences of the research participants in
context [58].
Study monitoring
Serious adverse events (any hospitalization of mother or
infant other than for delivery, congenital anomaly or
birth defect, persistent or significant disability, death)
identified by information from participants at data
collection points or using pre-paid change of circum-
stances cards, or from HES data at the conclusion of the
study, will be recorded using the NHS National Patient
Safety Agency form and reported by the chief investiga-
tor (CI) to the Multicenter Research Ethics Committee,
who gave a favorable opinion within 15 days of the CI
becoming aware of the event.
An independent Data Monitoring Committee (DMC)
has been established, whose remit is to review the trial’s
progress. Interim analyses will be supplied, in strict confi-
dence, to the DMC, as frequently as its Chair requests.
The terms of reference and a DMC charter [59] including
stopping guidance will be agreed at their first meeting.
Meetings of the committee will be arranged periodically,
as considered appropriate by the Chair. In the light of
interim data on the trial’s outcomes, adverse event data,
accumulating evidence from other trials and any other
relevant evidence (including updated overviews of the
relevant randomized controlled trials), the DMC will
inform the Trial Steering Committee (TSC) if in their view
there is proof beyond reasonable doubt that the data indi-
cate that any part of the protocol under investigation is
either clearly indicated or contra-indicated, either for all
or for a particular subgroup of trial participants. Unless
modification or cessation of the trial is recommended by
the DMC, the TSC, investigators, collaborators and ad-
ministrative staff (except those who supply the confiden-
tial information) will remain blind to the results of the
interim analysis. Collaborators and all others associated
with the study may write to the DMC via the Trial
Co-ordinating Center, to draw attention to any concern
they may have about the possibility of harm arising from
the treatment under study.
Discussion
The study is dependent on local community midwifery
teams identifying potentially eligible participants and
asking them to sign a simple form so that their contact
details can be shared with the research team. Thus, it
has been necessary to develop strong links with local
midwifery in each site and to tailor the collection of the
contact details forms to suit the way each team works.
The FNP teams also have to have close links with mid-
wifery since they are jointly responsible for delivering
midwifery care to women in the intervention arm of the
trial. That has meant a substantial amount of time had
been required for meetings and other liaison for the re-
search team and for each local FNP team but it is clear
that without close cooperation of all local midwives the
required number of eligible women in each site with
EDDs (only up to six weeks apart) will not be identified
in the short time frame that is necessary. We believe
that the necessary groundwork has been made and hope
that the next publication about this trial will concern its
results, demonstrating whether there is an impact on
parenting and other aspects of maternal well-being. This
is the first study to examine the effectiveness of gFNP in
the UK. Results should inform decision-making about its
delivery to vulnerable families not eligible for FNP,
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potentially enabling a wider range to benefit from the
FNP curriculum approach to supporting parenting.
Trial status
Recruitment will begin in late July 2013 and continue
until January 2014.
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